136 related articles for article (PubMed ID: 20409860)
1. Angiotensin receptor blockers vs. angiotensin converting enzyme inhibitors and acute coronary syndrome outcomes in elderly patients: a population-based cohort study (UMPIRE study results).
Verma S; Mamdani MM; Al-Omran M; Melo M; Rouleau JL
J Am Soc Hypertens; 2007; 1(4):286-94. PubMed ID: 20409860
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
Vijan SG
J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
[TBL] [Abstract][Full Text] [Related]
3. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
4. Risk of Osteoporotic Fractures With Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Hypertensive Community-Dwelling Elderly.
Butt DA; Mamdani M; Gomes T; Lix L; Lu H; Tu K;
J Bone Miner Res; 2014 Nov; 29(11):2483-8. PubMed ID: 24806397
[TBL] [Abstract][Full Text] [Related]
5. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.
Antoniou T; Gomes T; Juurlink DN; Loutfy MR; Glazier RH; Mamdani MM
Arch Intern Med; 2010 Jun; 170(12):1045-9. PubMed ID: 20585070
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease.
Singh JP; Kulik A; Levin R; Ellinor PT; Ruskin J; Avorn J; Choudhry NK
Europace; 2012 Sep; 14(9):1287-93. PubMed ID: 22539600
[TBL] [Abstract][Full Text] [Related]
7. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
Milicić D
Acta Med Croatica; 2004; 58(2):129-34. PubMed ID: 15208798
[TBL] [Abstract][Full Text] [Related]
8. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on major adverse cardiac events in patients with newly diagnosed type 2 diabetes: a nationwide study.
Shih CJ; Chu H; Ou SM; Chen YT
Int J Cardiol; 2015 Nov; 199():283-9. PubMed ID: 26218587
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
Lip GY; Frison L; Grind M
J Intern Med; 2007 Jun; 261(6):577-86. PubMed ID: 17547713
[TBL] [Abstract][Full Text] [Related]
11. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice.
Kassab YW; Hassan Y; Aziz NA; Akram H; Ismail O
J Eval Clin Pract; 2013 Aug; 19(4):658-63. PubMed ID: 22845427
[TBL] [Abstract][Full Text] [Related]
12. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?
Ong HT
J Am Board Fam Med; 2009; 22(6):686-97. PubMed ID: 19897698
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Lim S; Choo EH; Choi IJ; Ihm SH; Kim HY; Ahn Y; Chang K; Jeong MH; Seung KB
J Korean Med Sci; 2019 Nov; 34(45):e289. PubMed ID: 31760711
[TBL] [Abstract][Full Text] [Related]
14. CAC score as a possible criterion for administration of angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers: the MultiEthnic Study of Atherosclerosis.
Darabian S; Luo Y; Homat A; Khosraviani K; Wong N; Zeb I; Nasir K; Budoff MJ
Coron Artery Dis; 2015 Dec; 26(8):678-85. PubMed ID: 26398149
[TBL] [Abstract][Full Text] [Related]
15. Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromes.
Singh SM; Goodman SG; Yan RT; Dery JP; Wong GC; Gallo R; Grondin FR; Lai K; Lopez-Sendon J; Fox KA; Yan AT;
Am J Cardiol; 2012 Feb; 109(3):332-6. PubMed ID: 22078966
[TBL] [Abstract][Full Text] [Related]
16. Effects of the Renin-Angiotensin system blockade on hemoglobin levels in type 2 diabetic patients with chronic kidney disease.
Inoue A; Babazono T; Iwamoto Y
Am J Hypertens; 2008 Mar; 21(3):317-22. PubMed ID: 18202667
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
18. Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction.
Milonas C; Jernberg T; Lindbäck J; Agewall S; Wallentin L; Stenestrand U;
Am J Cardiol; 2010 May; 105(9):1229-34. PubMed ID: 20403471
[TBL] [Abstract][Full Text] [Related]
19. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
[TBL] [Abstract][Full Text] [Related]
20. Have angiotensin receptor blockers lived up to expectations?
Fitchett D
Can J Cardiol; 2005 May; 21(7):569-75. PubMed ID: 15940354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
